This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CytRx Corp (CYTR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 22.26M 32.22M 11.48M 14.34M
Receivables 4.62M 2.12M 125.99K 136.32K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 64.29M 83.21M 41.02M 39.69M
Property, Plant & Equipment, Gross 1.84M 1.42M 513.45K 483.28K
Accumulated Depreciation & Depletion 375.00K 446.13K 338.00K 230.00K
Property, Plant & Equipment, Net 1.47M 970.87K 175.45K 253.28K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.08M 1.32M 117.00K 102.27K
Total Non-Current Assets 2.73M 2.48M 476.23K 539.33K
Liabilities & Shareholder Equity
Total Assets 67.02M 85.69M 41.50M 40.23M
Accounts Payable 8.06M 6.66M 3.85M 3.06M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 5.19M 8.08M 26.32M 6.31M
Total Current Liabilities 22.95M 17.78M 30.84M 10.07M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 0.00 0.00 0.00
Total Liabilities 22.95M 17.78M 30.84M 10.07M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 44.08M 67.91M 10.66M 30.17M
Common Par 66.48K 55.92K 42.12K 30.61K
Additional Paid In Capital 409.11M 376.98M 289.43M 261.32M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -365.09M -306.51M -276.39M -228.90M
Treasury Stock 0.00 -2.61M -2.42M -2.28M
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 44.08M 67.91M 10.66M 30.17M
Total Equity 44.08M 67.91M 10.66M 30.17M
Total Liabilities & Stock Equity 67.02M 85.69M 41.50M 40.23M
Total Common Shares Outstanding 66.48M 55.92M 42.12M 30.61M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 199.28K 143.80K 90.55K
Basic Weighted Shares Outstanding 60.48M 54.37M 32.89M 22.97M
Diluted Weighted Shares Outstanding 60.48M 54.37M 32.89M 22.97M
Number of Employees 31 26 17 15
Number of Part-Time Employees 0 0 0 0
CYTR News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for CYTR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CYTR ANALYST REPORT

CYTR Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs